 | • レポートコード：QYR9ST04697 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、退形成性乏星細胞腫の世界市場について調査・分析し、退形成性乏星細胞腫の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線）、用途別（病院、癌センター、手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の退形成性乏星細胞腫市場動向 ・主要企業別マーケットシェア ・退形成性乏星細胞腫の種類別市場規模2014-2019 （化学療法、放射線） ・退形成性乏星細胞腫の用途別市場規模2014-2019 （病院、癌センター、手術センター） ・退形成性乏星細胞腫の北米市場：主要企業・種類別/用途別市場規模 ・退形成性乏星細胞腫のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・退形成性乏星細胞腫の中国市場：主要企業・種類別/用途別市場規模 ・退形成性乏星細胞腫の日本国内市場：主要企業・種類別/用途別市場規模 ・退形成性乏星細胞腫の東南アジア市場：主要企業・種類別/用途別市場規模 ・退形成性乏星細胞腫のインド市場：主要企業・種類別/用途別市場規模 ・退形成性乏星細胞腫の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Tocagen、Shandong Lanjin Pharmaceuticals、Keryx Biopharmaceuticals、Insys Therapeutics、Rush University Medical Center） ・退形成性乏星細胞腫の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic. According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear to be grade 4. Anaplastic oligoastrocytomas can be characterized by high cellularity, conspicuous cytologic atypism, microvascular proliferation, mitotic activity and necrosis. Patients suffering from this condition show symptoms like headache, seizure and speech or motor changes. According to the American Brain Cancer Association, clinical trials for the treatment of this tumor are in process to minimize the recurrence rate of anaplastic oligoastocytoma caused after the surgical removal of tumor or chemotherapy and radiation therapy session.Anaplastic oligoastrocytomas market is offers potential opportunities to cancer care industry. Factors contributing the growth of anaplastic oligoastrocytomas market are rising geriatric population, increasing incidence of anaplastic oligoastrocytomas and increasing pace of clinical trials for novel drug development. Moreover factors such as advancement in technology and innovations in diangositc techniques is expected to drive the growth of anaplastic oligoastrocytoma market over the forecast period. However, lack of specific treatment and critical diagnosis of anaplastic oligoastrocytoma is the major challenge for anaplastic oligoastrocytomas market.
In 2018, the global Anaplastic Oligoastrocytoma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Anaplastic Oligoastrocytoma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anaplastic Oligoastrocytoma development in United States, Europe and China.
The key players covered in this study
Tocagen
Shandong Lanjin Pharmaceuticals
Keryx Biopharmaceuticals
Insys Therapeutics
Rush University Medical Center
…
Market segment by Type, the product can be split into
Chemotherapy
Radiation
Market segment by Application, split into
Hospitals
Cancer Centers
Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Anaplastic Oligoastrocytoma status, future forecast, growth opportunity, key market and key players.
To present the Anaplastic Oligoastrocytoma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Anaplastic Oligoastrocytoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anaplastic Oligoastrocytoma Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation
1.5 Market by Application
1.5.1 Global Anaplastic Oligoastrocytoma Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer Centers
1.5.4 Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Anaplastic Oligoastrocytoma Market Size
2.2 Anaplastic Oligoastrocytoma Growth Trends by Regions
2.2.1 Anaplastic Oligoastrocytoma Market Size by Regions (2014-2025)
2.2.2 Anaplastic Oligoastrocytoma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Anaplastic Oligoastrocytoma Market Size by Manufacturers
3.1.1 Global Anaplastic Oligoastrocytoma Revenue by Manufacturers (2014-2019)
3.1.2 Global Anaplastic Oligoastrocytoma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anaplastic Oligoastrocytoma Market Concentration Ratio (CR5 and HHI)
3.2 Anaplastic Oligoastrocytoma Key Players Head office and Area Served
3.3 Key Players Anaplastic Oligoastrocytoma Product/Solution/Service
3.4 Date of Enter into Anaplastic Oligoastrocytoma Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Anaplastic Oligoastrocytoma Market Size by Type (2014-2019)
4.2 Global Anaplastic Oligoastrocytoma Market Size by Application (2014-2019)
5 United States
5.1 United States Anaplastic Oligoastrocytoma Market Size (2014-2019)
5.2 Anaplastic Oligoastrocytoma Key Players in United States
5.3 United States Anaplastic Oligoastrocytoma Market Size by Type
5.4 United States Anaplastic Oligoastrocytoma Market Size by Application
6 Europe
6.1 Europe Anaplastic Oligoastrocytoma Market Size (2014-2019)
6.2 Anaplastic Oligoastrocytoma Key Players in Europe
6.3 Europe Anaplastic Oligoastrocytoma Market Size by Type
6.4 Europe Anaplastic Oligoastrocytoma Market Size by Application
7 China
7.1 China Anaplastic Oligoastrocytoma Market Size (2014-2019)
7.2 Anaplastic Oligoastrocytoma Key Players in China
7.3 China Anaplastic Oligoastrocytoma Market Size by Type
7.4 China Anaplastic Oligoastrocytoma Market Size by Application
8 Japan
8.1 Japan Anaplastic Oligoastrocytoma Market Size (2014-2019)
8.2 Anaplastic Oligoastrocytoma Key Players in Japan
8.3 Japan Anaplastic Oligoastrocytoma Market Size by Type
8.4 Japan Anaplastic Oligoastrocytoma Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Anaplastic Oligoastrocytoma Market Size (2014-2019)
9.2 Anaplastic Oligoastrocytoma Key Players in Southeast Asia
9.3 Southeast Asia Anaplastic Oligoastrocytoma Market Size by Type
9.4 Southeast Asia Anaplastic Oligoastrocytoma Market Size by Application
10 India
10.1 India Anaplastic Oligoastrocytoma Market Size (2014-2019)
10.2 Anaplastic Oligoastrocytoma Key Players in India
10.3 India Anaplastic Oligoastrocytoma Market Size by Type
10.4 India Anaplastic Oligoastrocytoma Market Size by Application
11 Central & South America
11.1 Central & South America Anaplastic Oligoastrocytoma Market Size (2014-2019)
11.2 Anaplastic Oligoastrocytoma Key Players in Central & South America
11.3 Central & South America Anaplastic Oligoastrocytoma Market Size by Type
11.4 Central & South America Anaplastic Oligoastrocytoma Market Size by Application
12 International Players Profiles
12.1 Tocagen
12.1.1 Tocagen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anaplastic Oligoastrocytoma Introduction
12.1.4 Tocagen Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)
12.1.5 Tocagen Recent Development
12.2 Shandong Lanjin Pharmaceuticals
12.2.1 Shandong Lanjin Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anaplastic Oligoastrocytoma Introduction
12.2.4 Shandong Lanjin Pharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)
12.2.5 Shandong Lanjin Pharmaceuticals Recent Development
12.3 Keryx Biopharmaceuticals
12.3.1 Keryx Biopharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anaplastic Oligoastrocytoma Introduction
12.3.4 Keryx Biopharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)
12.3.5 Keryx Biopharmaceuticals Recent Development
12.4 Insys Therapeutics
12.4.1 Insys Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anaplastic Oligoastrocytoma Introduction
12.4.4 Insys Therapeutics Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)
12.4.5 Insys Therapeutics Recent Development
12.5 Rush University Medical Center
12.5.1 Rush University Medical Center Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anaplastic Oligoastrocytoma Introduction
12.5.4 Rush University Medical Center Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)
12.5.5 Rush University Medical Center Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Anaplastic Oligoastrocytoma Key Market Segments
Table Key Players Anaplastic Oligoastrocytoma Covered
Table Global Anaplastic Oligoastrocytoma Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Anaplastic Oligoastrocytoma Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Figures
Table Key Players of Radiation
Table Global Anaplastic Oligoastrocytoma Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer Centers Case Studies
Figure Surgical Centers Case Studies
Figure Anaplastic Oligoastrocytoma Report Years Considered
Table Global Anaplastic Oligoastrocytoma Market Size 2014-2025 (Million US$)
Figure Global Anaplastic Oligoastrocytoma Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Anaplastic Oligoastrocytoma Market Size by Regions 2014-2025 (Million US$)
Table Global Anaplastic Oligoastrocytoma Market Size by Regions 2014-2019 (Million US$)
Table Global Anaplastic Oligoastrocytoma Market Share by Regions 2014-2019
Figure Global Anaplastic Oligoastrocytoma Market Share by Regions 2014-2019
Figure Global Anaplastic Oligoastrocytoma Market Share by Regions 2019
Table Market Top Trends
Table Global Anaplastic Oligoastrocytoma Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Anaplastic Oligoastrocytoma Market Share by Manufacturers (2014-2019)
Figure Global Anaplastic Oligoastrocytoma Market Share by Manufacturers in 2018
Table Global Anaplastic Oligoastrocytoma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anaplastic Oligoastrocytoma Product/Solution/Service
Table Date of Enter into Anaplastic Oligoastrocytoma Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anaplastic Oligoastrocytoma Market Size by Type (2014-2019) (Million US$)
Table Global Anaplastic Oligoastrocytoma Market Size Share by Type (2014-2019)
Figure Global Anaplastic Oligoastrocytoma Market Size Market Share by Type (2014-2019)
Table Global Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table Global Anaplastic Oligoastrocytoma Market Size Share by Application (2014-2019)
Figure Global Anaplastic Oligoastrocytoma Market Size Market Share by Application (2014-2019)
Figure Global Anaplastic Oligoastrocytoma Revenue Market Share by Application in 2018
Figure United States Anaplastic Oligoastrocytoma Market Size 2014-2019 (Million US$)
Table United States Key Players Anaplastic Oligoastrocytoma Revenue (2018-2019) (Million US$)
Table United States Key Players Anaplastic Oligoastrocytoma Market Share (2018-2019)
Table United States Anaplastic Oligoastrocytoma Market Size by Type (2014-2019) (Million US$)
Table United States Anaplastic Oligoastrocytoma Market Share by Type (2014-2019)
Table United States Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table United States Anaplastic Oligoastrocytoma Market Share by Application (2014-2019)
Figure Europe Anaplastic Oligoastrocytoma Market Size 2014-2019 (Million US$)
Table Europe Key Players Anaplastic Oligoastrocytoma Revenue (2018-2019) (Million US$)
Table Europe Key Players Anaplastic Oligoastrocytoma Market Share (2018-2019)
Table Europe Anaplastic Oligoastrocytoma Market Size by Type (2014-2019) (Million US$)
Table Europe Anaplastic Oligoastrocytoma Market Share by Type (2014-2019)
Table Europe Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table Europe Anaplastic Oligoastrocytoma Market Share by Application (2014-2019)
Figure China Anaplastic Oligoastrocytoma Market Size 2014-2019 (Million US$)
Table China Key Players Anaplastic Oligoastrocytoma Revenue (2018-2019) (Million US$)
Table China Key Players Anaplastic Oligoastrocytoma Market Share (2018-2019)
Table China Anaplastic Oligoastrocytoma Market Size by Type (2014-20189) (Million US$)
Table China Anaplastic Oligoastrocytoma Market Share by Type (2014-2019)
Table China Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table China Anaplastic Oligoastrocytoma Market Share by Application (2014-2019)
Figure Japan Anaplastic Oligoastrocytoma Market Size 2014-2019 (Million US$)
Table Japan Key Players Anaplastic Oligoastrocytoma Revenue (2018-2019) (Million US$)
Table Japan Key Players Anaplastic Oligoastrocytoma Market Share (2018-2019)
Table Japan Anaplastic Oligoastrocytoma Market Size by Type (2014-2019) (Million US$)
Table Japan Anaplastic Oligoastrocytoma Market Share by Type (2014-2019)
Table Japan Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table Japan Anaplastic Oligoastrocytoma Market Share by Application (2014-2019)
Figure Southeast Asia Anaplastic Oligoastrocytoma Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Anaplastic Oligoastrocytoma Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Anaplastic Oligoastrocytoma Market Share (2018-2019)
Table Southeast Asia Anaplastic Oligoastrocytoma Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Anaplastic Oligoastrocytoma Market Share by Type (2014-2019)
Table Southeast Asia Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Anaplastic Oligoastrocytoma Market Share by Application (2014-2019)
Figure India Anaplastic Oligoastrocytoma Market Size 2014-2019 (Million US$)
Table India Key Players Anaplastic Oligoastrocytoma Revenue (2018-2019) (Million US$)
Table India Key Players Anaplastic Oligoastrocytoma Market Share (2018-2019)
Table India Anaplastic Oligoastrocytoma Market Size by Type (2014-2019) (Million US$)
Table India Anaplastic Oligoastrocytoma Market Share by Type (2014-2019)
Table India Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table India Anaplastic Oligoastrocytoma Market Share by Application (2014-2019)
Figure Central & South America Anaplastic Oligoastrocytoma Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Anaplastic Oligoastrocytoma Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Anaplastic Oligoastrocytoma Market Share (2018-2019)
Table Central & South America Anaplastic Oligoastrocytoma Market Size by Type (2014-2019) (Million US$)
Table Central & South America Anaplastic Oligoastrocytoma Market Share by Type (2014-2019)
Table Central & South America Anaplastic Oligoastrocytoma Market Size by Application (2014-2019) (Million US$)
Table Central & South America Anaplastic Oligoastrocytoma Market Share by Application (2014-2019)
Table Tocagen Company Details
Table Tocagen Revenue in Anaplastic Oligoastrocytoma Business (2014-2019) (Million US$)
Figure Tocagen Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2014-2019)
Table Tocagen Recent Development
Table Shandong Lanjin Pharmaceuticals Company Details
Table Shandong Lanjin Pharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)(Million US$)
Figure Shandong Lanjin Pharmaceuticals Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2014-2019)
Table Shandong Lanjin Pharmaceuticals Recent Development
Table Keryx Biopharmaceuticals Company Details
Table Keryx Biopharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)(Million US$)
Figure Keryx Biopharmaceuticals Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2014-2019)
Table Keryx Biopharmaceuticals Recent Development
Table Insys Therapeutics Company Details
Table Insys Therapeutics Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)(Million US$)
Figure Insys Therapeutics Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2014-2019)
Table Insys Therapeutics Recent Development
Table Rush University Medical Center Company Details
Table Rush University Medical Center Revenue in Anaplastic Oligoastrocytoma Business (2014-2019)(Million US$)
Figure Rush University Medical Center Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2014-2019)
Table Rush University Medical Center Recent Development
Table Global Anaplastic Oligoastrocytoma Market Size by Regions (Million US$) 2019-2025
Figure Global Anaplastic Oligoastrocytoma Market Size Share by Regions (2019-2025)
Figure Global Anaplastic Oligoastrocytoma Market Size Share by Regions in 2025
Figure United States Anaplastic Oligoastrocytoma Market Size Forecast (2019-2025)(Million USD)
Figure Europe Anaplastic Oligoastrocytoma Market Size Forecast (2019-2025)(Million USD)
Figure China Anaplastic Oligoastrocytoma Market Size Forecast (2019-2025)(Million USD)
Figure Japan Anaplastic Oligoastrocytoma Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Anaplastic Oligoastrocytoma Market Size Forecast (2019-2025)(Million USD)
Figure India Anaplastic Oligoastrocytoma Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Anaplastic Oligoastrocytoma Market Size Forecast (2019-2025)(Million USD)
Table Global Anaplastic Oligoastrocytoma Market Size by Product (2019-2025) (Million US$)
Figure Global Anaplastic Oligoastrocytoma Market Size by Product (2019-2025)
Figure Global Anaplastic Oligoastrocytoma Market Size by Product in 2025
Table Global Anaplastic Oligoastrocytoma Market Size by Application (2019-2025) (Million US$)
Figure Global Anaplastic Oligoastrocytoma Market Size by Application (2019-2025)
Figure Global Anaplastic Oligoastrocytoma Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の未分化リンパ腫キナーゼ阻害剤市場：動向・競争分析 ALK inhibitors are potential anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation.[In 2018, the global Anaplastic Lymphoma Kinase Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CA…- 結腸がんの世界市場：市場規模・現状・予測 Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps throug…
- ホルモン不応性前立腺癌(HRPCA)の世界市場：市場規模・現状・予測 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 子宮内膜癌の世界市場：市場規模・現状・予測 Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual per…
- 非黒色腫皮膚癌の世界市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…